(by Tyler Durden | Zero Hedge) – Last week, the FDA authorized two much-hyped antiviral treatments for COVID (just in time for Christmas): Merck’s Molnupiravir and Pfizer’s Paxlovid. Almost immediately after the first data were released, critics were questioning the drugs’ safety profile. But now that the first courses of these “miracle” drugs are finding their way into patients’ bloodstreams, the mainstream media apparently now feels it’s safe to share some of these criticisms with the public. To wit, NBC News reports that these medications will require “careful monitoring” by prescribing doctors. This could create problems and make doctors more reluctant […]

Get The Word Out

This post was originally published on this site